Guillem Pina Laguna

Title: Guillem Pina Laguna: Innovator in Therapeutic Methods

Introduction

Guillem Pina Laguna is a notable inventor based in Mataró, Barcelona, Spain. He has made significant contributions to the field of therapeutics, particularly through his innovative patent. His work focuses on methods of administering a specific compound that has potential applications in treating various diseases.

Latest Patents

Guillem Pina Laguna holds a patent for a method of administering a therapeutically effective amount of 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione. This compound, referred to as Compound (1), is a PPAR-γ agonist that is utilized in the treatment of diseases such as nonalcoholic steatohepatitis and central nervous system disorders, including X-linked adrenoleukodystrophy and Friedreich's Ataxia. The patent outlines methods for achieving a threshold steady-state plasma concentration of this compound in patients.

Career Highlights

Guillem Pina Laguna is associated with Minoryx Therapeutics S.L., a company dedicated to developing innovative therapies for rare diseases. His work at Minoryx Therapeutics highlights his commitment to advancing medical science and improving patient outcomes through targeted therapeutic strategies.

Collaborations

Guillem collaborates with esteemed colleagues, including Marc Martinell Pedemonte and Maria Pilar Pizcueta Lalanza. These partnerships enhance the research and development efforts at Minoryx Therapeutics, fostering an environment of innovation and collaboration.

Conclusion

Guillem Pina Laguna is a prominent figure in the field of therapeutics, with a focus on innovative methods for treating complex diseases. His contributions through his patent and work at Minoryx Therapeutics reflect his dedication to advancing healthcare solutions.